Recombinant BTLA Protein, Rhesus (His Tag) Recombinant Proteins The BTLA (EHH16054.1) (Met1-Leu155) was expressed with a polyhistidine tag at the C-terminus The recombinant BTLA consists of 166a.a and predicts a molecular weight of 19.3 kDa.
$ $99 In stock
Formulation: The recombinant BTLA consists of 166a.a and predicts a molecular weight of 19.3 kDa.
Source: HEK293 Cells
Usage: Our products are for research use only. This product is not intended or approved for human, diagnostics or veterinary use

Recombinant BTLA Protein, Rhesus (His Tag)

Formulation: Recombinant BTLA Protein was lyophilized from sterile PBS, pH 7.4.1

Source: HEK293 Cells

Product Name Recombinant BTLA Protein, Rhesus (His Tag)
Product Type Recombinant Protein
Source HEK293 Cells
Formulation Recombinant BTLA Protein was lyophilized from sterile PBS, pH 7.4.1
Molecular Weight The recombinant BTLA consists of 166a.a and predicts a molecular weight of 19.3 kDa.
Endotoxin < 1.0 EU per μg protein as determined by the LAL method
Purity Greater than 85%as determined by SDS-PAGE.
Description The BTLA (EHH16054.1) (Met1-Leu155) was expressed with a polyhistidine tag at the C-terminus
Host Species Rhesus
Usage Our products are for research use only. This product is not intended or approved for human, diagnostics or veterinary use
Storage Store recombinant protein under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
AA Sequence Met1-Leu155
Product Background BTLA is a inhibitory molecule which belongs to the Ig superfamily. It down-modulates immune responses. As such, reagents that regulate the binding of BTLA to its ligand or alter BTLA signaling have significant therapeutic promise. BTLA is crucial to understand the mechanism(s) of action of these antibodies before attempting clinical applications. BTLA is not expressed by naive T cells, but it is induced during activation and remains expressed on T helper type 1 (T(H)1) but not T(H)2 cells. BTLA is a third inhibitory receptor on T lymphocytes with similarities to cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and programmed death 1 (PD-1).Immune CheckpointImmune Checkpoint TargetsCo-inhibitory Immune Checkpoint Targets ImmunotherapyCancer ImmunotherapyTargeted Therapy
Terminal Met 1
Bioactivity Please contact us for detailed information